Drug-regulated expression of Plasmodium falciparum P-glycoprotein homologue 1: A putative role for nuclear receptors

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 4, 2008, Pages 1438-1445

  Johnson, David J ^a   Owen, Andrew ^b   Plant, Nick ^c   Bray, Patrick G ^a   Ward, Stephen A ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CHLOROQUINE; DIHYDROFOLATE REDUCTASE; FOLIC ACID ANTAGONIST; MULTIDRUG RESISTANCE PROTEIN 1; PHENOBARBITAL; UBIQUINOL CYTOCHROME C REDUCTASE;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EXPOSURE; DRUG MECHANISM; DRUG SENSITIVITY; GENE; GENE CONTROL; GENOME ANALYSIS; MALARIA; MUTATION; PHENOTYPE; PLASMODIUM FALCIPARUM; PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTICONVULSANTS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; GENE EXPRESSION REGULATION; HUMANS; P-GLYCOPROTEIN; PARASITIC SENSITIVITY TESTS; PHENOBARBITAL; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 42049087373     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01392-07     Document Type: Article

References (49)

1. Bookout, A. L., Y. Jeong, M. Downes, R. T. Yu, R. M. Evans, and D. J. Mangelsdorf. 2006. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126:789-799.
2. Burk, O., K. A. Arnold, A. Geick, H. Tegude, and M. Eichelbaum. 2005. A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol. Chem. 386:503-513.
3. Cowman, A. F. 1991. The P-glycoprotein homologues of Plasmodium falciparum: are they involved in chloroquine resistance? Parasitol. Today 7:70-76.
4. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
5. Endicott, J. A., and V. Ling. 1989. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev, Biochem. 58:137-171.
6. Fidock, D. A., T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov, M. T. Ferdig, L. M. Ursos, A. B. Sidhu, B. Naude, K. W. Deitsch, X. Z. Su, J. C. Wootton, P. D. Roepe, and T. E. Wellems. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.
7. Foote, S. J., J. K. Thompson, A. F. Cowman, and D. J. Kemp. 1989. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57:921-930.
8. Goodwin, B., L. B. Moore, C. M. Stoltz, D. D. McKee, and S. A. Kliewer. 2001. Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol. Pharmacol. 60:427-431.
9. Greenwood, B. 2002. The molecular epidemiology of malaria. Trop. Med. Int. Health 7:1012-1021.
10. Honkakoski, P., R. Moore, K. A. Washburn, and M. Negishi. 1998. Activation by diverse xenochemicals of the 51-base pair phenobarbital-responsive enhancer module in the CYP2B10 gene. Mol. Pharmacol. 53:597-601.
11. Honkakoski, P., I. Zelko, T. Sueyoshi, and M. Negishi. 1998. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol. Cell. Biol. 18:5652-5658.
12. Horrocks, P., K. Dechering, and M. Lanzer. 1998. Control of gene expression in Plasmodium falciparum. Mol. Biochem. Parasitol. 95:171-181.
13. Jigorel, E., M. Le Vee, C. Boursier-Neyret, Y. Parmentier, and O. Fardel. 2006. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab. Dispos. 34:1756-1763.
14. Johnson, D. J., D. A. Fidock, M. Mungthin, V. Lakshmanan, A. B. Sidhu, P. G. Bray, and S. A. Ward. 2004. Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol. Cell 15:867-877.
15. Kast, H. R., B. Goodwin, P. T. Tarr, S. A. Jones, A. M. Anisfeld, C. M. Stoltz, P. Tontonoz, S. Kliewer, T. M. Willson, and P. A. Edwards. 2002. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. 277:2908-2915.
16. Kodama, S., and M. Negishi. 2006. Phenobarbital confers its diverse effects by activating the orphan nuclear receptor car. Drug Metab. Rev. 38:75-87.
17. Krogstad, D. J., I. Y. Gluzman, D. E. Kyle, A. M. Oduola, S. K. Martin, W. K. Milhous, and P. H. Schlesinger. 1987. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238:1283-1285.
18. Lakshmanan, V., P. G. Bray, D. Verdier-Pinard, D. J. Johnson, P. Horrocks, R. A. Muhle, G. E. Alakpa, R. H. Hughes, S. A. Ward, D. J. Krogstad, A. B. Sidhu, and D. A. Fidock. 2005. A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance. EMBO J. 24: 2294-2305.
19. Lehmann, J. M., D. D. McKee, M. A. Watson, T. M. Willson, J. T. Moore, and S. A. Kliewer. 1998. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Investig. 102:1016-1023.
20. Myrick, A., A. Munasinghe, S. Patankar, and D. F. Wirth. 2003. Mapping of the Plasmodium falciparum multidrug resistance gene 5′-upstream region, and evidence of induction of transcript levels by antimalarial drugs in chloroquine sensitive parasites. Mol. Microbiol. 49:671-683.
21. Ndifor, A. M., R. E. Howells, P. G. Bray, J. L. Ngu, and S. A. Ward. 1993. Enhancement of drug susceptibility in Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors. Antimicrob. Agents Chemother. 37:1318-1323.
22. Ndifor, A. M., S. A. Ward, and R. E. Howells. 1990. Cytochrome P-450 activity in malarial parasites and its possible relationship to chloroquine resistance. Mol. Biochem. Parasitol. 41:251-257.
23. Nelson, A. L., A. Purfield, P. McDaniel, N. Uthaimongkol, N. Buathong, S. Sriwichai, R. S. Miller, C. Wongsrichanalai, and S. R. Meshnick. 2005. pfmdr1 genotyping and in vivo mefloquine resistance on the Thai-Myanmar border. Am. J. Trop. Med. Hyg. 72:586-592.
24. Peel, S. A. 2001. The ABC transporter genes of Plasmodium falciparum and drug resistance. Drug Resist. Updat. 4:66-74.
25. Peel, S. A., P. Bright, B. Yount, J. Handy, and R. S. Baric. 1994. A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 51:648-658.
26. Price, R. N., C. Cassar, A. Brockman, M. Duraisingh, M. van Vugt, N. J. White, F. Nosten, and S. Krishna. 1999. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother. 43:2943-2949.
27. Price, R. N., A. C. Uhlemann, A. Brockman, R. McGready, E. Ashley, L. Phaipun, R. Patel, K. Laing, S. Looareesuwan, N. J. White, F. Nosten, and S. Krishna. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364:438-447.
28. Quandt, K., K. Freeh, H. Karas, E. Wingender, and T. Werner. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23: 4878-4884.
29. Rabinovich, S. A., I. M. Kulikovskaya, E. V. Maksakovskaya, T. V. Chekhonadskikh, T. G. Pankova, and R. I. Salganik. 1987. Suppression of the chloroquine resistance of Plasmodium berghei by treatment of infected mice with a microsomal monooxygenase inhibitor. Bull. W. H. O. 65:387-389.
30. Reed, M. B., K. J. Saliba, S. R. Caruana, K. Kirk, and A. F. Cowman. 2000. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403:906-909.
31. Rencurel, F., A. Stenhouse, S. A. Hawley, T. Friedberg, D. G. Hardie, C. Sutherland, and C. R. Wolf. 2005. AMP-activated protein kinase mediates phenobarbital induction of CYP2B gene expression in hepatocytes and a newly derived human hepatoma cell line. J. Biol. Chem. 280:4367-4373.
32. Ritchie, G. Y., M. Mungthin, J. E. Green, P. G. Bray, S. R. Hawley, and S. A. Ward. 1996. In vitro selection of halofantrine resistance in Plasmodium falciparum is not associated with increased expression of Pgh1. Mol. Biochem, Parasitol. 83:35-46.
33. Rosario, V. 1981. Cloning of naturally occurring mixed infections of malaria parasites. Science 212:1037-1038.
34. Salphati, L., and L. Z. Benet. 1998. Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers. Biochem. Pharmacol. 55:387-395.
35. Schuetz, E. G., W. T. Beck, and J. D. Schuetz. 1996. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol. Pharmacol. 49:311-318.
36. Schuetz, E. G., A. H. Schinkel, M. V. Relling, and J. D. Schuetz. 1996. P-glycoprotein: a major determinant of rifampicin-induciblc expression of cytochrome P4503A in mice and humans. Proc. Natl. Acad. Sci. USA 93: 4001-4005.
37. Sidhu, A. B., A. C. Uhlemann, S. G. Valderramos, J. C. Valderramos, S. Krishna, and D. A. Fidock. 2006. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 194: 528-535.
38. Sidhu, A. B., S. G. Valderramos, and D. A. Fidock. 2005. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol. Microbiol. 57:913-926.
39. Sidhu, A. B., D. Verdier-Pinard, and D. A. Fidock. 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298:210-213.
40. Squires, E. J., T. Sueyoshi, and M. Negishi. 2004. Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver. J. Biol. Chem. 279:49307-49314.
41. Staudinger, J. L., A. Madan, K. M. Carol, and A. Parkinson. 2003. Regulation of drug transporter gene expression by nuclear receptors. Drug Metab. Dispos. 31:523-527.
42. Sueyoshi, T., and M. Negishi. 2001. Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu. Rev. Pharmacol. Toxicol. 41:123-143.
43. Surolia, N., G. Karthikeyan, and G. Padmanaban. 1993. Involvement of cytochrome P-450 in conferring chloroquine resistance to the malarial parasite, Plasmodium falciparum. Biochem. Biophys. Res. Commun. 197:562-569.
44. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
45. Waller, K. L., R. A. Muhle, L. M. Ursos, P. Horrocks, D. Verdier-Pinard, A. B. Sidhu, H. Fujioka, P. D. Roepe, and D. A. Fidock. 2003. Chloroquine resistance modulated in vitro by expression levels of the Plasmodium falciparum chloroquine resistance transporter. J. Biol. Chem. 278:33593-33601.
46. Willson, T. M., and S. A. Kliewer. 2002. PXR, CAR and drug metabolism. Nat. Rev. Drug Discov. 1:259-266.
47. Wilson, C. M., A. E. Serrano, A. Wasley, M. P. Bogenschutz, A. H. Shankar, and D. F. Wirth. 1989. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 244:1184-1186.
48. Xie, W., J. L. Barwick, C. M. Simon, A. M. Pierce, S. Safe, B. Blumberg, P. S. Guzelian, and R. M. Evans. 2000. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev. 14: 3014-3023.
49. Zhang, Z., P. E. Burch, A. J. Cooney, R. B. Lanz, F. A. Pereira, J. Wu, R. A. Gibbs, G. Weinstock, and D. A. Wheeler. 2004. Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome. Genome Res. 14:580-590.